National Academies Press: OpenBook
« Previous: 5 Directions for the Future
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

A
References

Althuis, M. D., K. S. Moghissi, C. L. Westhoff, B. Scoccia, E. J. Lamb, J. H. Lubin, and L. A. Brinton. 2005. Uterine cancer after use of clomiphene citrate to induce ovulation. American Journal of Epidemiology 161(7):607-615.

Barbarino-Monnier, P., B. Gobert, F. Guillet-Rosso, M. C. Bene, P. Landes, and G. Faure. 1991. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertility and Sterility 56(5):928-932.

Bellver, J., E. A. Muñoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simón, A. Pellicer, and J. Remohi. 2003. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: A randomized controlled study. Human Reproduction 18(11):2283-2288.

Borten, M. 1980. Laparoscopic complications: Prevention and management. Philadelphia: BC Decker.

Brinton, L. A., B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb. 2004. Breast cancer risk associated with ovulation-stimulating drugs. Human Reproduction 19(9):2005-2013.

Budev, M. M., A. C. Arroliga, and T. Falcone. 2005. Ovarian hyperstimulation syndrome. Critical Care Medicine 33(10 Suppl): p. S301-S306.

Caligara, C., J. Navarro, G. Vargas, C. Simón, A. Pellicer, and J. Remohi. 2001. The effect of repeated controlled ovarian stimulation in donors. Human Reproduction 16(11):2320-2323.

CDC. Centers for Disease Control and Prevention. Assisted reproductive technology success rates. http://www.cdc.gov/ART/ART2003/index.htm (accessed December 22, 2006).

Coroleu, B., F. Lopez Mourelle, L. Hereter, A. Veiga, G. Calderón, F. Martinez, O. Carreras, and P. N. Barri. 1997. Ureteral lesion secondary to vaginal ultrasound follicular puncture for Oocyte recovery in in-vitro fertilization. Human Reproduction 12(5):948-950.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

de Boer, E. J., I. Den Tonkelaar, C. W. Burger, C. W. N. Looman, F. E. van Leeuwen, E. R. Velde, M. Kortman, N. Macklon, C. A. M. Jansen, R. A. Leerentveld, W. N. P. Willemsen, R. Schats, N. Naaktgeboren, F. M. Helmerhorst, R. S. G. M. Bots, A. H. M. Simons, H. V. Hogerzeil, J. L. H. Evers, and P. A. van Dop. 2004. The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Human Reproduction 19(4):899-904.

Delvigne, A. and S. Rozenberg, Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update, 2002. 8(6): p.559-77.

Dicker, D., J. Ashkenazi, D. Feldberg, T. Levy, A. Dekel, and Z. Ben-Rafael. 1993. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertility and Sterility 59(6):1313-1315.

Ditkoff, E. C., J. Plumb, A. Selick, and M. V. Sauer. 1997. Anesthesia practices in the United States common to in vitro fertilization (IVF) centers. Journal of Assisted Reproduction and Genetics 14(3):145-147.

Elkington, N. M., J. Kehoe, and U. Acharya. 2003. Recommendations for good practice for sedation in assisted conception. Human Fertility 6(2):77-80.

Fugita, O. E., and L. Kavoussi. 2001. Laparoscopic ureteral reimplantation for ureteral lesion secondary to transvaginal ultrasonography for oocyte retrieval. Urology 58(2):281i-281iii.

Garcia-Velasco, J. A., V. Isaza, G. Quea, and A. Pellicer. 2006. Coasting for the prevention of ovarian hyperstimulation syndrome: Much ado about nothing? Fertility and Sterility 85(3):547-554.

Gobert, B., P. Barbarino-Monnier, F. Guillet-May, M. C. Bene, and G. C. Faure. 1992. Anti-ovary antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation. Journal of Reproduction and Fertility 96(1):213-218.

Gorrill, M. J., L. K. Johnson, P. E. Patton, and K. A. Burry. 2001. Oocyte donor screening: The selection process and cost analysis. Fertility and Sterility 75(2):400-404.

Govaerts, I., F. Devreker, A. Delbaere, P. Revelard, and Y. Englert. 1998. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. European Journal of Obstetrics Gynecology and Reproductive Biology 77(2):239-243.

Greenfeld, D. A., C. M. Mazure, D. L. Olive, and D. L. Keefe. 1995. Similarities and differences between anonymous and directed candidates for oocyte donation. Journal of Assisted Reproduction and Genetics 12(2):118-122.

Hall, V. J., D. Compton, P. Stojkovic, M. Nesbitt, M. Herbert, A. Murdoch, and M. Stojkovic. 2007. Developmental competence of human in vitro aged oocytes as host cells for nuclear transfer. Human Reproduction 22(1):52-62.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

Hohmann, F. P., N. S. Macklon, and B. C. J. M. Fauser. 2003. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism 88(1):166-173.

Jordan, C. B., C. D. Belar, and R. S. Williams. 2004. Anonymous oocyte donation: A follow-up analysis of donors’ experiences. Journal of Psychosomatic Obstetrics and Gynecology 25(2):145-151.

Kalfoglou, A. L., and G. Geller. 2000. A follow-up study with oocyte donors exploring their experiences, knowledge, and attitudes about the use of their oocytes and the outcome of the donation. Fertility and Sterility 74(4):660-667.

Kalfoglou, A. L., and J. Gittelsohn. 2000. A qualitative follow-up study of women’s experiences with oocyte donation. Human Reproduction 15(4):798-805.

Kashyap, S., D. Moher, M. F. K. Fung, and Z. Rosenwaks. 2004. Assisted reproductive technology and the incidence of ovarian cancer: A meta-analysis. Obstetrics and Gynecology 103(4):785-794.

Klemetti, R., T. Sevon, M. Gissler, and E. Hemminki. 2005. Complications of IVF and ovulation induction. Human Reproduction 20(12):3293-3300.

Klock, S. C., A. M. Braverman, and D. T. Rausch. 1998. Predicting anonymous egg donor satisfaction: A preliminary study. Journal of Women’s Health 7(2):229-237.

Klock, S. C., J. E. Stout, and M. Davidson. 2003. Psychological characteristics and factors related to willingness to donate again among anonymous oocyte donors. Fertility and Sterility 79(6):1312-1316.

Lagasse, R. S. 2002. Anesthesia safety: Model or myth? A review of the published literature and analysis of current original data. Anesthesiology 97(6):1609-1617.

Lavoir, M. C., J. Weier, J. Conaghan, and R. A. Pedersen. 2005. Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reproductive BioMedicine Online 11(6):740-744.

Lessor, R., N. Cervantes, N. O’Connor, J. Balmaceda, and R. H. Asch. 1993. An analysis of social and psychological characteristics of women volunteering to become oocyte donors. Fertility and Sterility 59(1):65-71.

Ludwig, A. K., M. Glawatz, G. Griesinger, K. Diedrich, and M. Ludwig. 2006. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: Prospective study of >1000 oocyte retrievals. Human Reproduction 21(12):3235-3240.

Marina, S., R. Expósito, F. Marina, J. Nadal, M. Masramón, and A. Vergés. 1999. Oocyte donor selection from 554 candidates. Human Reproduction 14(11):2770-2776.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

Mashiach, S., D. Bider, O. Moran, M. Goldenberg, and Z. Ben-Rafael. 1990. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertility and Sterility 53(1):76-80.

McGee, E. A., and A. J. W. Hsueh. 2000. Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews 21(2):200-214.

Miller, P. B., T. Price, J. E. Nichols Jr., and L. Hill. 2002. Acute ureteral obstruction following transvaginal oocyte retrieval for IVF. Human Reproduction 17(1):137-138.

Ness, R. B., D. W. Cramer, M. T. Goodman, S. K. Kjaer, K. Mallin, B. J. Mosgaard, D. M. Purdie, H. A. Risch, R. Vergona, and A. H. Wu. 2002. Infertility, fertility drugs, and ovarian cancer: A pooled analysis of case-control studies. American Journal of Epidemiology 155(3):217-224.

Partrick, M., A. L. Smith, W. R. Meyer, and R. A. Bashford. 2001. Anonymous oocyte donation: A follow-up questionnaire. Fertility and Sterility 75(5):1034-1036.

Practice Committee of the American Society for Reproductive Medicine. 2004. Repetitive oocyte donation. Fertility and Sterility 82(SUPPL. 1): S158-S159.

Rizk, B., and M. Aboulghar. 1991. Modern management of ovarian hyperstimulation syndrome. Human Reproduction 6(8):1082-1087.

Rjosk, H. K., H. Haeske-Seeberg, B. Seeberg, and E. Kreuzer. 1995. IVF and GIFT—Ergebnisse in Deutschland 1993. Fertilität 11:48-54.

Rosenberg, H., and Y. Epstein. 1995. Follow-up study of anonymous ovum donors. Human Reproduction 10(10):2741-2747.

Salhab, M., W. Al Sarakbi, and K. Mokbel. 2005. In vitro fertilization and breast cancer risk: A review. International Journal of Fertility and Women’s Medicine 50(6):259-266.

Sauer, M. V. 1996. Laparoscopy after multiple follicle aspirations fails to demonstrate pathology in oocyte donors. Journal of Assisted Reproduction and Genetics 13(5):450-452.

———. 2001. Defining the incidence of serious complications experienced by oocyte donors: A review of 1000 cases. American Journal of Obstetrics and Gynecology 184(3):277-278.

Sauer, M. V., and R. J. Paulson. 1992. Oocyte donors: A demographic analysis of women at the University of Southern California. Human Reproduction 7(5):726-728.

Schenker, J. G., and Y. Ezra. 1994. Complications of assisted reproductive techniques. Fertility and Sterility 61(3):411-22.

Schover, L. R., R. L. Collins, M. M. Quigley, J. Blankstein, and G. Kanoti. 1991. Psychological follow-up of women evaluated as oocyte donors. Human Reproduction 6(10):1487-1491.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

Schover, L. R., J. Reis, R. L. Collins, J. Blankstein, G. Kanoti, and M. M. Quigley. 1990. The psychological evaluation of oocyte donors. Journal of Psychosomatic Obstetrics and Gynaecology 11(4):299-309.

Steinbrook, R. 2006. Egg donation and human embryonic stem-cell research. New England Journal of Medicine 354(4):324-326.

Tsen, L. C., and D. L. Hepner. 2006. Needles used for spinal anesthesia. Expert Review of Medical Devices 3(4):499-508.

Tsen, L. C., M. Natale, S. Datta, and S. Eappen. 2001. Can estrogen influence the response to noxious stimuli? Journal of Clinical Anesthesia 13(2):118-121.

Warner, M. A., S. E. Shields, and C. G. Chute. 1993. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. Journal of the American Medical Association 270(12):1437-1441.

Wu, C. L., S. M. Berenholtz, P. J. Pronovost, and L. A. Fleisher. 2002. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 96(4):994-1003.

Zeleznik, A. J. 2004. The physiology of follicle selection. Reproductive Biology and Endocrinology [electronic resource]: RB&E 2(1):31.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×

This page intentionally left blank.

Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 61
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 62
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 63
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 64
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 65
Suggested Citation:"Appendix A References." Institute of Medicine and National Research Council. 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11832.
×
Page 66
Next: Appendix B Public Workshop on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research »
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report Get This Book
×
Buy Paperback | $41.00 Buy Ebook | $32.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

It is widely understood that stem cell treatments have the potential to revolutionize medicine. Because of this potential, in 2004 California voters approved Proposition 71 to set up a 10-year, $3 billion program to fund research on stem cells. Under the direction of the California Institute for Regenerative Medicine, this program will pay to build facilities for stem cell research and will fund doctors and scientists to carry out research with the ultimate goal of helping to develop therapies based on stem cells.

For this research to move forward, however, will require a steady supply of stem cells, particularly human embryonic stem cells. Those stem cells are collected from developing human embryos created from eggs—or oocytes—harvested from the ovaries of female donors. Thus much of the promise of stem cells depends on women choosing to donate oocytes to the research effort.

The oocyte donation process is not without risk, however. Donors are given doses of hormones to trigger the production of more eggs than would normally be produced, and this hormone treatment can have various side effects. Once the eggs have matured in the ovary, they must be retrieved via a surgical procedure that is typically performed under anesthesia, and both the surgery and the anesthesia carry their own risks. Furthermore, given the very personal nature of egg donation, the experience may carry psychological risks for some women as well.

With this in mind, in 2006 the California Institute for Regenerative Medicine contracted with the National Academies to organize a workshop that would bring together experts from various areas to speak about the potential risks of oocyte donation and to summarize what is known and what needs to be known about this topic. The Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research was formed to plan the workshop, which was held in San Francisco on September 28, 2006. This report is a summary and synthesis of that workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!